Christine A Conelea1, Michael R Walther2, Jennifer B Freeman2, Abbe M Garcia2, Jeffrey Sapyta3, Muniya Khanna4, Martin Franklin5. 1. Bradley/Hasbro Children's Research Center and Alpert Medical School of Brown University, Providence, RI. Electronic address: christine_conelea@brown.edu. 2. Bradley/Hasbro Children's Research Center and Alpert Medical School of Brown University, Providence, RI. 3. Duke University Medical Center, Durham, NC. 4. Children and Adult's Center for Obsessive-Compulsive Disorder (OCD) and Anxiety, Plymouth Meeting, PA. 5. University of Pennsylvania School of Medicine, Philadelphia.
Abstract
OBJECTIVE: Prior research has shown that youth with co-occurring tic disorders and obsessive-compulsive disorder (OCD) may differ from those with non-tic-related OCD in terms of clinical characteristics and treatment responsiveness. A broad definition of "tic-related" was used to examine whether children with tics in the Pediatric OCD Treatment Study II differed from those without tics in terms of demographic and phenomenological characteristics and acute treatment outcomes. METHOD:Participants were 124 youth aged 7 to 17 years, inclusive, with a primary diagnosis of OCD who were partial responders to an adequate serotonin reuptake inhibitor (SRI) trial. Participants were randomized to medication management, medication management plus instructions in cognitive-behavioral therapy (CBT), or medication management plus full CBT. Tic status was based on the presence of motor and/or vocal tics on the Yale Global Tic Severity Scale. RESULTS:Tics were identified in 53% of the sample. Those with tic-related OCD did not differ from those with non-tic-related OCD in terms of age, family history of tics, OCD severity, OCD-related impairment, or comorbidity. Those with tics responded equally in all treatment conditions. CONCLUSION: Tic-related OCD was very prevalent using a broad definition of tic status. Results suggest that youth with this broad definition of tic-related OCD do not have increased OCD severity or inference, higher comorbidity rates or severity, or worsened functioning, and support the use of CBT in this population. This highlights the importance of not making broad assumptions about OCD symptoms most likely to occur in an individual with comorbid tics. Clinical trial registration information-Treatment of Pediatric OCD for SRI Partial Responders; http://clinicaltrials.gov; NCT00074815.
RCT Entities:
OBJECTIVE: Prior research has shown that youth with co-occurring tic disorders and obsessive-compulsive disorder (OCD) may differ from those with non-tic-related OCD in terms of clinical characteristics and treatment responsiveness. A broad definition of "tic-related" was used to examine whether children with tics in the Pediatric OCD Treatment Study II differed from those without tics in terms of demographic and phenomenological characteristics and acute treatment outcomes. METHOD:Participants were 124 youth aged 7 to 17 years, inclusive, with a primary diagnosis of OCD who were partial responders to an adequate serotonin reuptake inhibitor (SRI) trial. Participants were randomized to medication management, medication management plus instructions in cognitive-behavioral therapy (CBT), or medication management plus full CBT. Tic status was based on the presence of motor and/or vocal tics on the Yale Global Tic Severity Scale. RESULTS: Tics were identified in 53% of the sample. Those with tic-related OCD did not differ from those with non-tic-related OCD in terms of age, family history of tics, OCD severity, OCD-related impairment, or comorbidity. Those with tics responded equally in all treatment conditions. CONCLUSION:Tic-related OCD was very prevalent using a broad definition of tic status. Results suggest that youth with this broad definition of tic-related OCD do not have increased OCD severity or inference, higher comorbidity rates or severity, or worsened functioning, and support the use of CBT in this population. This highlights the importance of not making broad assumptions about OCD symptoms most likely to occur in an individual with comorbid tics. Clinical trial registration information-Treatment of Pediatric OCD for SRI Partial Responders; http://clinicaltrials.gov; NCT00074815.
Authors: Helena da Silva Prado; Maria Conceição do Rosário; Roseli Gedanke Shavitt; Eurípedes Constantino Miguel Journal: CNS Spectr Date: 2007-02 Impact factor: 3.790
Authors: J Freeman; J Sapyta; A Garcia; D Fitzgerald; M Khanna; M Choate-Summers; P Moore; A Chrisman; N Haff; A Naeem; J March; M Franklin Journal: Child Psychiatry Hum Dev Date: 2011-08
Authors: James F Leckman; Damiaan Denys; H Blair Simpson; David Mataix-Cols; Eric Hollander; Sanjaya Saxena; Euripedes C Miguel; Scott L Rauch; Wayne K Goodman; Katharine A Phillips; Dan J Stein Journal: Depress Anxiety Date: 2010-06 Impact factor: 6.505
Authors: Maria Conceição do Rosario-Campos; James F Leckman; Mariana Curi; Susan Quatrano; Lylia Katsovitch; Euripedes C Miguel; David L Pauls Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2005-07-05 Impact factor: 3.568
Authors: Cara W J Verdellen; Cees A L Hoogduin; Bernet S Kato; Ger P J Keijsers; Danielle C Cath; Herbert B Hoijtink Journal: Behav Modif Date: 2008-03
Authors: Eric A Storch; Lisa J Merlo; Michael J Larson; Gary R Geffken; Heather D Lehmkuhl; Marni L Jacob; Tanya K Murphy; Wayne K Goodman Journal: J Am Acad Child Adolesc Psychiatry Date: 2008-05 Impact factor: 8.829
Authors: Matti Cervin; Sean Perrin; Elin Olsson; Kristina Aspvall; Daniel A Geller; Sabine Wilhelm; Joseph McGuire; Luisa Lázaro; Agustin E Martínez-González; Barbara Barcaccia; Andrea Pozza; Wayne K Goodman; Tanya K Murphy; İsmail Seçer; José A Piqueras; Tiscar Rodríguez-Jiménez; Antonio Godoy; Ana I Rosa-Alcázar; Ángel Rosa-Alcázar; Beatriz M Ruiz-García; Eric A Storch; David Mataix-Cols Journal: J Am Acad Child Adolesc Psychiatry Date: 2019-08-14 Impact factor: 8.829
Authors: Joseph F McGuire; John Piacentini; Adam B Lewin; Erin A Brennan; Tanya K Murphy; Eric A Storch Journal: Depress Anxiety Date: 2015-06-30 Impact factor: 6.505
Authors: Tamara Pringsheim; Michael S Okun; Kirsten Müller-Vahl; Davide Martino; Joseph Jankovic; Andrea E Cavanna; Douglas W Woods; Michael Robinson; Elizabeth Jarvie; Veit Roessner; Maryam Oskoui; Yolanda Holler-Managan; John Piacentini Journal: Neurology Date: 2019-05-07 Impact factor: 11.800
Authors: Gustaf Brander; Ralf Kuja-Halkola; Mina A Rosenqvist; Christian Rück; Eva Serlachius; Lorena Fernández de la Cruz; Paul Lichtenstein; James J Crowley; Henrik Larsson; David Mataix-Cols Journal: Mol Psychiatry Date: 2019-10-15 Impact factor: 15.992